NPI: 1760476659 · KNOXVILLE, TN 37916 · Rehabilitation Clinic/Center · NPI assigned 09/07/2005
Authorized official ROSENDAHL, ANDREW controls 20+ related entities in our dataset. Read more
| Authorized Official | ROSENDAHL, ANDREW (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 09/07/2005 |
Other providers sharing the same authorized official: ROSENDAHL, ANDREW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 155,288 | $11.15M |
| 2019 | 155,119 | $11.70M |
| 2020 | 107,608 | $8.51M |
| 2021 | 165,522 | $13.15M |
| 2022 | 183,592 | $13.60M |
| 2023 | 200,719 | $15.38M |
| 2024 | 190,162 | $15.12M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 129,862 | 125,040 | $27.22M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 48,668 | 46,819 | $13.30M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 8,798 | 7,996 | $6.76M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 33,874 | 32,805 | $5.08M |
| 41899 | Unlisted procedure, dentoalveolar structures | 4,847 | 4,643 | $3.43M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 4,866 | 4,475 | $2.22M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1,447 | 1,373 | $2.04M |
| G0378 | Hospital observation service, per hour | 3,327 | 2,977 | $2.00M |
| 95782 | 2,596 | 2,290 | $1.99M | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36,466 | 34,601 | $1.65M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 11,905 | 9,162 | $1.63M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 9,291 | 7,181 | $1.55M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20,305 | 19,445 | $1.48M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1,019 | 970 | $1.20M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 3,523 | 3,153 | $1.09M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,745 | 2,652 | $1.05M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4,115 | 3,973 | $927K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 13,197 | 12,905 | $923K |
| G0175 | Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present | 4,714 | 4,529 | $834K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 16,594 | 16,282 | $804K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 9,544 | 9,071 | $602K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7,362 | 2,906 | $579K |
| 93325 | 12,599 | 9,659 | $533K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,821 | 1,787 | $518K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6,377 | 6,220 | $515K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18,693 | 17,627 | $487K |
| 93320 | 11,917 | 9,167 | $412K | |
| 71046 | Radiologic examination, chest; 2 views | 32,906 | 31,746 | $375K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,545 | 1,641 | $371K |
| 36415 | Collection of venous blood by venipuncture | 120,930 | 98,733 | $355K |
| 95819 | 2,885 | 2,676 | $326K | |
| 81001 | 37,193 | 35,233 | $321K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3,263 | 1,222 | $312K |
| 94060 | 7,745 | 6,597 | $312K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 52,390 | 45,745 | $281K |
| 99215 | Prolong outpt/office vis | 4,462 | 4,092 | $273K |
| A0225 | Ambulance service, neonatal transport, base rate, emergency transport, one way | 807 | 717 | $257K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9,317 | 8,938 | $245K |
| 74019 | 23,141 | 22,150 | $232K | |
| 87400 | 34,776 | 33,496 | $207K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 7,710 | 7,260 | $205K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 39,470 | 32,935 | $191K |
| 94010 | 7,720 | 6,500 | $176K | |
| 72146 | 530 | 521 | $165K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 519 | 511 | $161K |
| 72141 | 543 | 537 | $156K | |
| 80053 | Comprehensive metabolic panel | 22,481 | 20,864 | $148K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 23,130 | 22,212 | $145K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 21,118 | 20,343 | $120K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 309 | 275 | $120K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 4,226 | 4,078 | $107K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,948 | 5,711 | $105K |
| 76770 | 1,464 | 1,378 | $103K | |
| 95957 | 1,501 | 1,442 | $90K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,126 | 1,975 | $89K |
| 87807 | 10,491 | 10,179 | $88K | |
| 87581 | 4,126 | 3,981 | $87K | |
| 87486 | 4,116 | 3,973 | $87K | |
| 94760 | 19,678 | 18,952 | $83K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3,133 | 3,008 | $82K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,855 | 1,701 | $70K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 9,632 | 8,093 | $64K |
| 84443 | Thyroid stimulating hormone (TSH) | 6,103 | 5,926 | $61K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 435 | 376 | $60K |
| 93000 | 3,382 | 3,243 | $52K | |
| 97161 | 494 | 488 | $49K | |
| 97803 | 1,786 | 1,628 | $48K | |
| 99205 | Prolong outpt/office vis | 654 | 626 | $47K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,183 | 1,068 | $47K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,235 | 637 | $47K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5,267 | 4,533 | $47K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,195 | 7,800 | $44K |
| 70450 | Computed tomography, head or brain; without contrast material | 546 | 514 | $43K |
| 86140 | 13,666 | 12,980 | $41K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 6,712 | 6,527 | $39K |
| 87088 | 8,805 | 8,355 | $39K | |
| 74018 | 1,860 | 1,629 | $35K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 82 | 81 | $30K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 3,759 | 3,395 | $29K |
| 84439 | 5,012 | 4,870 | $26K | |
| 82570 | 4,991 | 4,307 | $26K | |
| 94664 | 2,322 | 2,255 | $23K | |
| 85045 | 1,311 | 1,136 | $23K | |
| 80061 | Lipid panel | 2,597 | 2,512 | $21K |
| 78227 | 62 | 62 | $21K | |
| 77072 | 753 | 734 | $20K | |
| L8699 | Prosthetic implant, not otherwise specified | 771 | 737 | $18K |
| 97802 | 554 | 534 | $17K | |
| 82043 | 389 | 347 | $17K | |
| 96156 | 224 | 216 | $16K | |
| 81025 | 4,375 | 4,142 | $15K | |
| 83525 | 703 | 675 | $12K | |
| 87632 | 107 | 101 | $12K | |
| 85730 | 2,196 | 2,133 | $12K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 666 | 642 | $11K |
| 96361 | Intravenous infusion, hydration; each additional hour | 438 | 392 | $10K |
| 83690 | 995 | 938 | $10K | |
| 92526 | 174 | 89 | $9K | |
| 94762 | 1,664 | 909 | $9K | |
| 83655 | 671 | 657 | $8K | |
| 85610 | 2,396 | 2,327 | $7K | |
| 95812 | 58 | 50 | $6K | |
| 99243 | 101 | 76 | $6K | |
| 82340 | 1,572 | 1,455 | $6K | |
| 82553 | 122 | 113 | $6K | |
| 85652 | 1,254 | 1,187 | $6K | |
| 95811 | 13 | 12 | $6K | |
| 97165 | 60 | 58 | $6K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 12 | 12 | $5K |
| J2704 | Injection, propofol, 10 mg | 22,594 | 15,656 | $5K |
| 74240 | 90 | 89 | $5K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 293 | 279 | $5K |
| 86308 | 698 | 672 | $5K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 38 | 38 | $4K |
| 84156 | 2,891 | 2,365 | $4K | |
| 87040 | 492 | 452 | $4K | |
| 87070 | 788 | 735 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 143 | 130 | $4K |
| 82657 | 4,706 | 4,337 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 143 | 130 | $4K |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 62 | 62 | $4K |
| 82784 | 203 | 199 | $4K | |
| 86003 | 201 | 198 | $4K | |
| 82785 | 218 | 210 | $3K | |
| 82272 | 786 | 768 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 64 | 62 | $3K |
| 95251 | 75 | 73 | $3K | |
| 84100 | 337 | 316 | $2K | |
| 83001 | 81 | 74 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | 24 | 24 | $2K |
| 76857 | 56 | 51 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 203 | 163 | $2K |
| 54150 | 14 | 12 | $2K | |
| 81003 | 1,551 | 1,148 | $2K | |
| 84146 | 70 | 64 | $2K | |
| 75809 | 65 | 57 | $2K | |
| 85027 | 1,201 | 1,113 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 63 | 24 | $2K |
| 86258 | 115 | 112 | $2K | |
| 86364 | 115 | 112 | $2K | |
| 84550 | 264 | 246 | $2K | |
| 82150 | 561 | 524 | $2K | |
| A0425 | Ground mileage, per statute mile | 16 | 12 | $2K |
| 83516 | 59 | 59 | $2K | |
| 96040 | 43 | 40 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 10,378 | 9,366 | $1K |
| 82550 | 147 | 134 | $1K | |
| 80069 | 171 | 151 | $1K | |
| 87081 | 124 | 121 | $1K | |
| 83002 | 37 | 37 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 35 | 24 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,196 | 6,609 | $968.28 |
| 89220 | 111 | 109 | $960.92 | |
| 86769 | 26 | 24 | $926.88 | |
| 74455 | 13 | 13 | $926.38 | |
| 96167 | 14 | 13 | $856.66 | |
| J2805 | Injection, sincalide, 5 micrograms | 30 | 30 | $833.38 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 14 | 14 | $813.08 |
| 83013 | 14 | 13 | $741.04 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 57 | 54 | $680.24 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 234 | 155 | $657.73 |
| 93225 | 40 | 26 | $628.62 | |
| 83993 | 43 | 42 | $611.08 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 113 | 65 | $532.34 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 13,032 | 10,280 | $496.93 |
| 82247 | 70 | 63 | $475.68 | |
| 84484 | 66 | 66 | $469.48 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 6,333 | 5,789 | $468.17 |
| 82248 | 73 | 64 | $433.18 | |
| 83880 | 26 | 26 | $431.55 | |
| 71045 | Radiologic examination, chest; single view | 86 | 84 | $430.58 |
| 82728 | 107 | 91 | $402.72 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 957 | 873 | $390.65 |
| 82803 | 12 | 12 | $312.90 | |
| 83630 | 28 | 28 | $306.72 | |
| 86256 | 30 | 28 | $305.23 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 12,254 | 11,622 | $305.12 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 15 | 13 | $276.31 |
| 87186 | 29 | 25 | $256.41 | |
| 82962 | 58 | 48 | $241.86 | |
| 81015 | 205 | 199 | $178.05 | |
| 82977 | 152 | 144 | $175.81 | |
| 51600 | 13 | 13 | $167.60 | |
| 86255 | 17 | 15 | $163.83 | |
| 87045 | 12 | 12 | $132.42 | |
| 91035 | 14 | 12 | $131.50 | |
| 84030 | 151 | 132 | $123.12 | |
| 51701 | 601 | 578 | $123.00 | |
| 83550 | 41 | 39 | $104.53 | |
| 86038 | 60 | 59 | $94.56 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,224 | 829 | $92.42 |
| 76000 | 679 | 618 | $86.11 | |
| 88342 | 463 | 415 | $73.56 | |
| 83735 | 24 | 24 | $71.82 | |
| 83615 | 14 | 13 | $67.39 | |
| 87427 | 12 | 12 | $64.48 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 297 | 267 | $62.82 |
| 83540 | 27 | 26 | $61.53 | |
| 87210 | 12 | 12 | $61.50 | |
| 96160 | 14 | 13 | $47.74 | |
| 87046 | 12 | 12 | $35.43 | |
| 86225 | 12 | 12 | $26.85 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,384 | 2,203 | $16.97 |
| 86060 | 13 | 13 | $14.28 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 435 | 371 | $11.93 |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 15 | 13 | $6.30 |
| J3490 | Unclassified drugs | 229 | 203 | $4.75 |
| J3480 | Injection, potassium chloride, per 2 meq | 29 | 24 | $1.99 |
| J1170 | Injection, hydromorphone, up to 4 mg | 309 | 261 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 400 | 380 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 140 | 87 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 12 | 12 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 33 | 30 | $0.00 |
| 99188 | 827 | 779 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 285 | 277 | $0.00 |
| A4362 | Skin barrier; solid, 4 x 4 or equivalent; each | 45 | 44 | $0.00 |
| J0290 | Injection, ampicillin sodium, 500 mg | 87 | 73 | $0.00 |
| 84145 | 15 | 12 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 15 | 12 | $0.00 |